Meeting of the Tick-Borne Disease Working Group, 55553 [2018-24260]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) announces the
eighth meeting of the Tick-Borne
Disease Working Group (Working
Group) on December 3, 2018, from 1:00
p.m. to 4:00 p.m., Eastern Time. The
eighth meeting will be an online
meeting held via webcast. The Working
Group will review the work of the
public comments subcommittee, discuss
the release of the 2018 Report to
Congress, recognize the subcommittee
members for their contributions to the
2018 Report, and address the next steps
and transition to a new Working Group
for the 2020 Report to Congress.
DATES: The meeting will be held on
December 3, 2018, from 1:00 p.m. to
4:00 p.m., Eastern Time.
ADDRESSES: This will be an online
meeting that is held via webcast.
Members of the public may attend the
meeting via webcast. Instructions for
attending the meeting via webcast will
be posted one week prior to the meeting
at: https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
index.html.
SUMMARY:
khammond on DSK30JT082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov or by phone at 202–795–7697.
SUPPLEMENTARY INFORMATION: The
Working Group invites public comment
on issues related to the Working Group’s
charge. It may be provided via webcast
at the meeting or in writing. Persons
who wish to provide public comment
via webcast should review directions at
https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
index.html before submitting a request
to do so via email at tickbornedisease@
hhs.gov. Requests to provide webcast
comments are due on or before
November 26, 2018, and will be limited
to three minutes each to accommodate
as many speakers as possible. If more
requests are received than can be
accommodated, speakers will be
randomly selected. The nature of the
comments will not be considered in
VerDate Sep<11>2014
17:05 Nov 05, 2018
Jkt 247001
making this selection. Public comments
may also be provided in writing.
Individuals who would like to provide
written comments should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before sending
their comments to tickbornedisease@
hhs.gov on or before November 26,
2018. During the meeting, the Working
Group will review the work of the
public comments subcommittee, discuss
the release of the 2018 Report to
Congress, recognize the subcommittee
members for their contributions to the
2018 Report, and address the next steps
and transition to a new Working Group
for the 2020 Report to Congress.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review all HHS efforts related to tickborne diseases to help ensure
interagency coordination and minimize
overlap, examine research priorities,
and identify and address unmet needs.
In addition, the Working Group will
report to the Secretary and Congress on
their findings and any recommendations
for the federal response to tick-borne
disease prevention, treatment and
research, and addressing gaps in those
areas.
Dated: October 25, 2018.
James J. Berger,
Senior Advisor for Blood and Tissue Policy,
Designated Federal Officer, Tick-Borne
Disease Working Group.
[FR Doc. 2018–24260 Filed 11–5–18; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
[OIG–1810–N]
Statement of Organization, Functions,
and Delegations of Authority
Office of Inspector General
(OIG), HHS.
ACTION: Notice.
AGENCY:
This notice replaces all
language in Part Q (Office of the
Secretary) of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services (HHS or the Department),
Office of Inspector General (OIG) (81 FR
13807, as published March 15, 2016).
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
55553
The Statement of Organization,
Functions, and Delegations of Authority
conforms to and carries out the statutory
requirements for operating OIG. The
organizational changes reflected in this
notice are primarily to realign the
functions within OIG to better reflect
the current work environment and
priorities and to more clearly delineate
responsibilities for the various activities
within OIG’s offices.
OIG was established by law as an
independent and objective oversight
unit of the Department to carry out the
mission of preventing fraud and abuse
and promoting economy, efficiency, and
effectiveness of HHS programs and
operations. In furtherance of this
mission, the organization:
• Conducts and supervises audits,
investigations, evaluations, and
inspections relating to HHS programs
and operations;
• identifies systemic weaknesses
giving rise to opportunities for fraud
and abuse in HHS programs and
operations and makes recommendations
to prevent their recurrence;
• leads and coordinates activities to
prevent and detect fraud and abuse in
HHS programs and operations;
• detects wrongdoers and abusers of
HHS programs and beneficiaries so
appropriate remedies may be brought to
bear, including imposing administrative
sanctions against providers of health
care under Medicare and Medicaid who
commit certain prohibited acts; and
• keeps the Secretary of Health and
Human Services and Congress fully and
currently informed about problems and
deficiencies in the administration of
HHS programs and operations and about
the need for and progress of corrective
action.
In addition, OIG works with the
Department of Justice (DOJ), on behalf of
the Secretary, to operate the Health Care
Fraud and Abuse Control Program. In
accordance with authority enacted in its
annual appropriations, OIG also
provides protection services to the
Secretary and conducts criminal
investigations of violations of Federal
child support provisions.
In support of its mission, OIG carries
out and maintains an internal quality
assurance system and a peer-review
system with other Offices of Inspector
General, including periodic quality
assessment studies and quality control
reviews, to provide reasonable
assurance that applicable laws,
regulations, policies, procedures,
standards, and other requirements are
followed, are effective, and are
functioning as intended in OIG
operations.
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
[Federal Register Volume 83, Number 215 (Tuesday, November 6, 2018)]
[Notices]
[Page 55553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24260]
[[Page 55553]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) announces
the eighth meeting of the Tick-Borne Disease Working Group (Working
Group) on December 3, 2018, from 1:00 p.m. to 4:00 p.m., Eastern Time.
The eighth meeting will be an online meeting held via webcast. The
Working Group will review the work of the public comments subcommittee,
discuss the release of the 2018 Report to Congress, recognize the
subcommittee members for their contributions to the 2018 Report, and
address the next steps and transition to a new Working Group for the
2020 Report to Congress.
DATES: The meeting will be held on December 3, 2018, from 1:00 p.m. to
4:00 p.m., Eastern Time.
ADDRESSES: This will be an online meeting that is held via webcast.
Members of the public may attend the meeting via webcast. Instructions
for attending the meeting via webcast will be posted one week prior to
the meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/.
FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the Assistant Secretary for
Health, Department of Health and Human Services; via email at
[email protected] or by phone at 202-795-7697.
SUPPLEMENTARY INFORMATION: The Working Group invites public comment on
issues related to the Working Group's charge. It may be provided via
webcast at the meeting or in writing. Persons who wish to provide
public comment via webcast should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before submitting a request to do so via email at
[email protected]. Requests to provide webcast comments are due
on or before November 26, 2018, and will be limited to three minutes
each to accommodate as many speakers as possible. If more requests are
received than can be accommodated, speakers will be randomly selected.
The nature of the comments will not be considered in making this
selection. Public comments may also be provided in writing. Individuals
who would like to provide written comments should review directions at
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before sending their comments to [email protected] on
or before November 26, 2018. During the meeting, the Working Group will
review the work of the public comments subcommittee, discuss the
release of the 2018 Report to Congress, recognize the subcommittee
members for their contributions to the 2018 Report, and address the
next steps and transition to a new Working Group for the 2020 Report to
Congress.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review all HHS
efforts related to tick-borne diseases to help ensure interagency
coordination and minimize overlap, examine research priorities, and
identify and address unmet needs. In addition, the Working Group will
report to the Secretary and Congress on their findings and any
recommendations for the federal response to tick-borne disease
prevention, treatment and research, and addressing gaps in those areas.
Dated: October 25, 2018.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Designated Federal Officer,
Tick-Borne Disease Working Group.
[FR Doc. 2018-24260 Filed 11-5-18; 8:45 am]
BILLING CODE 4150-28-P
